TORONTO, Jan. 09, 2023 (World NEWSWIRE) — Titan Professional medical Inc. (Nasdaq: TMDI TSX: TMD), a health care product enterprise targeted on the enhancement and commercialization of progressive surgical systems for one obtain robotic-assisted surgical procedure (RAS), these days announced the unveiling of its future era know-how and participation in conferences to support the strategic evaluation procedure introduced on November 30, 2022 alongside the 41st Yearly J.P. Morgan Health care Convention becoming held January 9-12 in San Francisco, CA. A online video highlighting the company’s most up-to-date innovation in robotic-assisted operation is accessible on the company’s website www.titanmedicalinc.com.
Cary G. Vance, Titan’s President and CEO, commented, “We are searching ahead to assembly with strategic purchasers and investors during the conference 7 days and offering a long run watch into what a a few-arm one accessibility robotic-assisted surgery technology could glance like. With the time it requires to convey elaborate solutions to market place in the regulated clinical unit sector, you need to continually visualize the following technology. Our aim on purpose-driven innovation has usually been at the forefront of our work. We are thrilled to share our three-arm style that was independently made by Titan and builds upon technologies created for our two-arm process and those generated less than a beforehand executed and accomplished progress and license settlement, and addresses evolving purchaser demands in one-obtain robotic surgical treatment.”
If you would like to timetable a assembly through the conference, be sure to email Kristen Galfetti at traders@titanmedicalinc.com.
About Titan Clinical
Titan Professional medical Inc. (Nasdaq: TMDI TSX: TMD), a health care system business headquartered in Toronto, Ontario with functions in Chapel Hill, North Carolina, is focused on maximizing robotic assisted surgical procedure (RAS) employing revolutionary technological innovation as a result of a solitary entry level. The Enos™ robotic single obtain surgical procedure is being designed with an ergonomic focus to provide a surgical working experience that imitates authentic-lifestyle movements that surgeons demand and contains multi-articulating devices created to make it possible for surgeons an elevated range of motion in a confined area, with dexterity and the skill to exert the forces required to total frequent surgical jobs. With the Enos procedure, Titan intends to in the beginning go after gynecologic surgical indications. On November 30, 2022, the organization declared the graduation of a strategic assessment system that will take into consideration a full vary of strategic options like corporate sale, merger or other company mixture, a sale of all or a portion of the company’s property, strategic financial investment or other sizeable transaction.
Enos™ is a trademark of Titan Health-related Inc.
For more information, go to www.titanmedicalinc.com and follow @TitanMedical on Twitter and LinkedIn.
Ahead-Hunting Statements
This news launch includes “forward-looking statements” in the meaning of relevant Canadian and U.S. securities legislation, which replicate the present anticipations of administration of the company’s upcoming development, final results of functions, general performance and organization potential clients and opportunities. Ahead-looking statements are frequently, but not constantly, identified by words and phrases this sort of as “may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and related expressions, despite the fact that these terms may perhaps not be present in all ahead-searching statements. Ahead-searching statements that appear in this launch could involve, without the need of limitation, references to: the company’s strategic overview procedure and the probable outcome thereof the company’s participation in conferences to assist the strategic evaluation process the company’s a few-arm single accessibility RAS engineering the company’s concentration on solitary entry robotic assisted surgery the Enos process giving a surgical experience that imitates genuine-lifestyle actions the Enos system currently being intended to market faster recovery, shorter medical center stays, lower possibility of infection, fewer scars and fewer submit-operative pain Titan’s mission of improving results for people, hospitals and surgeons and the company’s intention to at first pursue gynecologic surgical indications with the Enos process.
These ahead-on the lookout statements replicate management’s recent beliefs with respect to potential gatherings and are dependent on information at the moment readily available to administration that, whilst viewed as affordable by management as of the date on which the statements are made, are inherently subject matter to considerable enterprise, economic and competitive uncertainties and contingencies which could outcome in actions, gatherings, problems, benefits, general performance or achievements to be materially various from people projected in the ahead-searching statements. Ahead-on the lookout statements contain sizeable hazards, uncertainties and assumptions and a lot of elements could bring about the company’s precise benefits, general performance or achievements to be materially distinctive from any long term effects, general performance or achievements that may well be expressed or implied by such ahead-on the lookout statements. This kind of things and assumptions consist of, but are not constrained to, the Company’s capacity to retain crucial staff its potential to execute on its business enterprise ideas and methods the sufficiency of its performing cash to proceed to fund its functions throughout its strategic evaluation system and other aspects stated in the “Risk Factors” section of the company’s Annual Report for the fiscal year finished December 31, 2021 (which may be viewed at www.sedar.com and at www.sec.gov). Should a single or more of these pitfalls or uncertainties materialize, or ought to assumptions underlying the ahead-wanting statements establish incorrect, true benefits, general performance, or achievements might fluctuate materially from all those expressed or implied by the ahead-wanting statements contained in this information release. These aspects ought to be viewed as diligently, and prospective traders must not area undue reliance on the forward-hunting statements.
Even though the forward-wanting statements contained in the information release are based upon what administration currently thinks to be realistic assumptions and the business has attempted to detect critical factors that could lead to genuine actions, events, situations, outcomes, effectiveness or achievements to differ materially from those described in forward-hunting statements, the enterprise simply cannot assure future investors that real outcomes, overall performance or achievements will be consistent with these ahead-wanting statements. Except as necessary by law, the corporation expressly disclaims any intention or obligation to update or revise any forward-on the lookout statements no matter if as a consequence of new details, potential gatherings or in any other case. Appropriately, buyers must not put undue reliance on ahead-seeking statements. All the forward-on the lookout statements are expressly qualified by the foregoing cautionary statements.
Call
Kristen Galfetti
Vice President, Investor Relations
& Company Communications
+1-781-869-2553
buyers@titanmedicalinc.com
###
